Contraception in premenopausal women
https://doi.org/10.21518/2079-701X-2015-9-39-41
Abstract
The article tells about methods of contraception for women in premenopausal age. Levonorgestrel intrauterine device (LNG-IUD) is a highly effective method of contraception in this age group. Locally acting levonorgestrel reduces the duration of bleeding during menstruation and has a therapeutic benefit in the treatment of endometrial hyperplasia.
About the Authors
Y. E. Dobrokhotova
Medical Faculty of the Russian National Research Medical University named after N.I. Pirogov, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
L. V. Saprykina
Medical Faculty of the Russian National Research Medical University named after N.I. Pirogov, Ministry of Health of the Russian Federation, Moscow
Russian Federation
Russian Federation
References
1. Baldwin MK, Jensen JT. Contraception during the perimenopause. Maturitas, 2013, 76(3): 235-242.
2. Макаров И.О., Овсянникова Т.В., Шешукова Н.А. и др. Контрацепция в позднем репродуктивном и пременопаузальном периодах. Акушерство, гинекология, репродукция, 2010, 4(1): 12-15.
3. Прилепская В.Н. Контрацепция у женщин после 40 лет. Акушерство и гинекология, 1998, 4: 53-55.
4. Sivin I. Utility and drawbacks of continuous use of a copper T IUD for 20 years. Contraception, 2007, 75(6): 70-75.
5. Callaghan WM. Overview of maternal mortality in the United States. Seminars in Perinatology [Historical Article]. 2012. Vol. 36. P. 2-6.
6. Прилепская В.Н, Назарова Н.М. Изучение клинической эффективности микродозированного орального контрацептива Новинет у женщин в пременопаузе. Фарматека, 2003, 2: 8-10. 7. Batar I. State-of-the-art of non-hormonal methods of contraception: II. Chemical barrier contraceptives. Eur. J. Contracept. Reprod. Health Care, 2010, 15, 2: 89-95.
7. Miklavcic AY, Isaacs CR. Obstetric-gynecology resident education regarding barrier and over-the-counter contraceptives: a national study. J. Womens Health, 2012, 11: 1196-1200.
8. Speroff L, Darney PD. A clinical guide for contraception. 5th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2011.
9. Morelli M, La Ferrera N, Gallo F. Use of progesterone-releasing intra-uterine system in men-horragia relapse prevention after laparoscopic myomectomy. Minerva Ginecol., 2014, 66(5): 461-467.
10. Кузнецова И.В., Могиревская О.А., Якокутова М.В. и др. Дисфункциональные маточные кровотечения и простая гиперплазия эндометрия в пременопаузе: возможности гормональной коррекции. Российский вестник акушера-гинеколога, 2008, 5: 70-74.
11. Kayikcioglu F, Gunes M, Ozdegirmenci O, Effects of levonorgestrel-releasing intrauterine system on glucose and lipid metabolism: a 1-year follow-up study. Contraception, 2006, 73(5): 528-531.
12. Прилепская В.Н., Острейкова Л.И. Эволюция прогестагенов и прогресс современной контрацепции. Гинекология, 2004, 6(3): 111-113.
13. Perino A, Ouartararo P, Catinella E et al. Treatment of endometrial hyperplasia with lev-onorgestrel releasing intrauterine devices. Acta. Eur. Fertil., 1987, 18, 2: 137-140.
14. Гинекология: национальное руководство. Под ред. В.И. Кулакова, И.Б. Манухина, ГМ. Савельевой. М.: ГЭОТАР - Медиа, 2007. - 1072 с.
15. Доброхотова Ю.Э., Венедиктова М.Г., Сапрыкина Л.В. Эндохирургические методы лечения предраковых состояний эндометрия. Лечебное дело, 2010, 2: 66-69.
16. Orbo A, Vereide A, Arnes M, Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicen-tre randomised trial. BJOG, 2014, 121(4): 477-486.
Review
For citations:
Dobrokhotova YE, Saprykina LV. Contraception in premenopausal women. Meditsinskiy sovet = Medical Council. 2015;(9):39-41. (In Russ.) https://doi.org/10.21518/2079-701X-2015-9-39-41
Views:
440
Email this article 